QPPV.COM KNOWLEDGE ASSESSMENT

EU Pharmacovigilance Inspection Findings: Benefit–Risk Assessment and Decision-Making

Test your understanding of the concepts covered by EU Pharmacovigilance Inspection Findings: Benefit–Risk Assessment and Decision-Making.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement correctly distinguishes an MAH's internal assessment from a regulatory decision?

Any internal benefit–risk conclusion is legally equivalent to a competent-authority decision An MAH may assess evidence internally, while a competent authority or committee may later reach a regulatory conclusion under a formal procedure An MAH cannot conduct benefit–risk assessments unless a formal referral is underway A regulatory authority's position should always be recorded as the MAH's own conclusion

Question 2 of 10 Which approach best demonstrates appropriate handling of uncertainty in an inspection-relevant assessment?

State the conclusion with certainty so that decision-makers are not confused Exclude limitations because they weaken the regulatory position Identify material uncertainties and explain how they may influence the conclusion or selected action Delay every decision until all uncertainties have been resolved

Question 3 of 10 Which statement best describes proportionality in documentation of safety decisions?

Every decision requires a comprehensive scientific essay Only decisions resulting in regulatory action require documented reasoning Documentation should be sufficient to reconstruct the decision, taking account of its materiality, uncertainty and applicable process The shortest possible record is always preferable

Question 4 of 10 When a risk-minimisation measure is selected, which linkage should the organisation be able to explain?

How the measure was selected in relation to the identified risk and how its intended effect will be evaluated Why the measure eliminates the underlying risk completely Why effectiveness evaluation is unnecessary once implementation is documented Why the most restrictive available measure must always be used

Question 5 of 10 An organisation concludes that no further action is required but retains only a final conclusion and no supporting assessment. What is the principal inspection concern?

The organisation did not necessarily reach the scientifically correct conclusion The organisation cannot reconstruct the evidence and reasoning supporting a material decision Every no-action decision must result in a product-information change A no-action decision is invalid unless approved by a competent authority

Question 6 of 10 An assessment identifies a material concern, but the resulting action cannot be linked to the conclusion or stated rationale. Which potential weakness does this illustrate?

Decision/action disconnect Scientific certainty Automatic regulatory non-compliance caused by disagreement Adequate proportionality

Question 7 of 10 Which situation most clearly represents a process deficiency rather than merely a scientific difference of opinion?

Two experts assign different weights to observational and mechanistic evidence An assessment reaches a cautious conclusion despite inconsistent study findings Material contradictory evidence was available but was not considered or addressed A committee decides that the evidence remains inconclusive

Question 8 of 10 What is the QPPV's appropriate role in relation to material benefit–risk decisions?

Personally perform every scientific assessment Approve every individual case report before processing Maintain appropriate oversight and visibility and have sufficient access and authority to escalate concerns Replace the competent authority in making regulatory decisions

Question 9 of 10 Which evidence package would best support reconstruction of a material safety decision during inspection?

A current summary prepared by an employee who was not involved in the original decision The triggering information, contemporaneous assessment, governance record, decision rationale, action records and relevant follow-up A revised procedure showing how similar decisions should be made today Training attendance records for the assessors

Question 10 of 10 Which statement most accurately describes the inspection significance of uncertainty?

Any uncertainty proves that the assessment is inadequate Uncertainty is acceptable when it is recognised, evaluated and appropriately managed within the decision process Uncertainty should be excluded from decision records to avoid regulatory concern Uncertainty permits the organisation to bypass applicable governance

QPPV.com

EU Pharmacovigilance Inspection Findings: Benefit–Risk Assessment and Decision-Making

Cookie Settings